# The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA

> **NCT06069180** · PHASE4 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Severe Aplastic Anemia

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Flu/Cy/ATG or Cy/ATG

## Key facts

- **NCT ID:** NCT06069180
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069180, "The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06069180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*